{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:18:31Z","timestamp":1793837911624,"version":"4.6.1"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangdong Provincial Science and Technology Plan Project","award":["No.2015A020211003"],"award-info":[{"award-number":["No.2015A020211003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05382-6","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T08:07:18Z","timestamp":1781338038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["KLRB1 gene in tumor immune regulation and disease prognosis: a multidimensional role review"],"prefix":"10.1007","volume":"17","author":[{"given":"JiaMei","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"5382_CR1","doi-asserted-by":"crossref","unstructured":"Morch\u00f3n-Araujo D, Catani G, Mirallas O, Pretelli G, S\u00e1nchez-P\u00e9rez V, Vieito M et al. Emerging Immunotherapy Targets in Early Drug Development. Int J Mol Sci. 2025;26(11).","DOI":"10.3390\/ijms26115394"},{"key":"5382_CR2","doi-asserted-by":"publisher","first-page":"688215","DOI":"10.3389\/fimmu.2021.688215","volume":"12","author":"X Zhou","year":"2021","unstructured":"Zhou X, Du J, Liu C, Zeng H, Chen Y, Liu L, et al. A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint. Front Immunol. 2021;12:688215.","journal-title":"Front Immunol"},{"issue":"1","key":"5382_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10238-025-01826-5","volume":"25","author":"Q Meng","year":"2025","unstructured":"Meng Q, Liu H, Wang M, Jiang X, Wang Y, Cao X, et al. Identification of prognostic genes related to T cell proliferation in papillary thyroid cancer based on single-cell RNA sequencing and bulk RNA sequencing data. Clin Exp Med. 2025;25(1):273.","journal-title":"Clin Exp Med"},{"issue":"6","key":"5382_CR4","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.4049\/jimmunol.153.6.2417","volume":"153","author":"LL Lanier","year":"1994","unstructured":"Lanier LL, Chang C, Phillips JH, Human. NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol. 1994;153(6):2417\u201328.","journal-title":"J Immunol"},{"issue":"3","key":"5382_CR5","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.celrep.2014.09.045","volume":"9","author":"JR Fergusson","year":"2014","unstructured":"Fergusson JR, Smith KE, Fleming VM, Rajoriya N, Newell EW, Simmons R, et al. CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages. Cell Rep. 2014;9(3):1075\u201388.","journal-title":"Cell Rep"},{"key":"5382_CR6","doi-asserted-by":"publisher","first-page":"1040289","DOI":"10.3389\/fimmu.2022.1040289","volume":"13","author":"H Li","year":"2022","unstructured":"Li H, Zhou K, Wang K, Cao H, Wu W, Wang Z, et al. A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy. Front Immunol. 2022;13:1040289.","journal-title":"Front Immunol"},{"issue":"12","key":"5382_CR7","doi-asserted-by":"publisher","first-page":"7791","DOI":"10.4049\/jimmunol.175.12.7791","volume":"175","author":"H Aldemir","year":"2005","unstructured":"Aldemir H, Prod\u2019homme V, Dumaurier MJ, Retiere C, Poupon G, Cazareth J, et al. Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor. J Immunol. 2005;175(12):7791\u20135.","journal-title":"J Immunol"},{"issue":"8","key":"5382_CR8","doi-asserted-by":"publisher","first-page":"e1026503","DOI":"10.1080\/2162402X.2015.1026503","volume":"4","author":"C Germain","year":"2015","unstructured":"Germain C, Guillaudeux T, Galsgaard ED, Hervouet C, Tekaya N, Gallouet AS, et al. Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin\u2019s lymphomas dampening natural killer cell functions. Oncoimmunology. 2015;4(8):e1026503.","journal-title":"Oncoimmunology"},{"key":"5382_CR9","doi-asserted-by":"crossref","unstructured":"Buller CW, Mathew PA, Mathew SO. Roles of NK Cell Receptors 2B4 (CD244), CS1 (CD319), and LLT1 (CLEC2D) in Cancer. Cancers (Basel). 2020;12(7).","DOI":"10.3390\/cancers12071755"},{"issue":"5","key":"5382_CR10","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1073\/pnas.95.5.2446","volume":"95","author":"M Bl\u00e9ry","year":"1998","unstructured":"Bl\u00e9ry M, Kubagawa H, Chen CC, V\u00e9ly F, Cooper MD, Vivier E. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc Natl Acad Sci U S A. 1998;95(5):2446\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5382_CR11","doi-asserted-by":"publisher","first-page":"5254911","DOI":"10.1155\/2022\/5254911","volume":"2022","author":"X Cheng","year":"2022","unstructured":"Cheng X, Cao Y, Wang X, Cheng L, Liu Y, Lei J, et al. Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors. J Immunol Res. 2022;2022:5254911.","journal-title":"J Immunol Res"},{"issue":"8","key":"5382_CR12","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/art.30332","volume":"63","author":"L Cosmi","year":"2011","unstructured":"Cosmi L, Cimaz R, Maggi L, Santarlasci V, Capone M, Borriello F, et al. Evidence of the transient nature of the Th17 phenotype of CD4\u2009+\u2009CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum. 2011;63(8):2504\u201315.","journal-title":"Arthritis Rheum"},{"key":"5382_CR13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fimmu.2014.00214","volume":"5","author":"CL Kirkham","year":"2014","unstructured":"Kirkham CL, Carlyle JR. Complexity and Diversity of the NKR-P1:Clr (Klrb1:Clec2) Recognition Systems. Front Immunol. 2014;5:214.","journal-title":"Front Immunol"},{"issue":"1","key":"5382_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-022-01513-z","volume":"21","author":"K Yang","year":"2022","unstructured":"Yang K, Wu Z, Zhang H, Zhang N, Wu W, Wang Z, et al. Glioma targeted therapy: insight into future of molecular approaches. Mol Cancer. 2022;21(1):39.","journal-title":"Mol Cancer"},{"key":"5382_CR15","doi-asserted-by":"publisher","first-page":"613204","DOI":"10.3389\/fimmu.2020.613204","volume":"11","author":"V Konduri","year":"2020","unstructured":"Konduri V, Oyewole-Said D, Vazquez-Perez J, Weldon SA, Halpert MM, Levitt JM, et al. CD8(+)CD161(+) T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential. Front Immunol. 2020;11:613204.","journal-title":"Front Immunol"},{"issue":"8","key":"5382_CR16","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1084\/jem.20080397","volume":"205","author":"L Cosmi","year":"2008","unstructured":"Cosmi L, De Palma R, Santarlasci V, Maggi L, Capone M, Frosali F, et al. Human interleukin 17-producing cells originate from a CD161\u2009+\u2009CD4+ T cell precursor. J Exp Med. 2008;205(8):1903\u201316.","journal-title":"J Exp Med"},{"issue":"27","key":"5382_CR17","doi-asserted-by":"publisher","first-page":"23823","DOI":"10.1074\/jbc.M110.214254","volume":"286","author":"J Kamishikiryo","year":"2011","unstructured":"Kamishikiryo J, Fukuhara H, Okabe Y, Kuroki K, Maenaka K. Molecular basis for LLT1 protein recognition by human CD161 protein (NKRP1A\/KLRB1). J Biol Chem. 2011;286(27):23823\u201330.","journal-title":"J Biol Chem"},{"key":"5382_CR18","doi-asserted-by":"publisher","first-page":"847576","DOI":"10.3389\/fimmu.2022.847576","volume":"13","author":"VM Braud","year":"2022","unstructured":"Braud VM, Meghraoui-Kheddar A, Elaldi R, Petti L, Germain C, Anju\u00e8re F. LLT1-CD161 Interaction in Cancer: Promises and Challenges. Front Immunol. 2022;13:847576.","journal-title":"Front Immunol"},{"issue":"5","key":"5382_CR19","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/(SICI)1521-4141(199805)28:05<1611::AID-IMMU1611>3.0.CO;2-6","volume":"28","author":"A Poggi","year":"1998","unstructured":"Poggi A, Costa P, Tomasello E, Moretta L. IL-12-induced up-regulation of NKRP1A expression in human NK cells and consequent NKRP1A-mediated down-regulation of NK cell activation. Eur J Immunol. 1998;28(5):1611\u20136.","journal-title":"Eur J Immunol"},{"issue":"7","key":"5382_CR20","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.4049\/jimmunol.161.7.3493","volume":"161","author":"L Azzoni","year":"1998","unstructured":"Azzoni L, Zatsepina O, Abebe B, Bennett IM, Kanakaraj P, Perussia B. Differential transcriptional regulation of CD161 and a novel gene, 197\/15a, by IL-2, IL-15, and IL-12 in NK and T cells. J Immunol. 1998;161(7):3493\u2013500.","journal-title":"J Immunol"},{"key":"5382_CR21","doi-asserted-by":"crossref","unstructured":"Duurland CL, Santegoets SJ, Abdulrahman Z, Loof NM, Sturm G, Wesselink TH et al. CD161 expression and regulation defines rapidly responding effector CD4\u2009+\u2009T cells associated with improved survival in HPV16-associated tumors. J Immunother Cancer. 2022;10(1).","DOI":"10.1136\/jitc-2021-003995"},{"issue":"3","key":"5382_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.20411\/pai.v2i3.136","volume":"2","author":"ML Freeman","year":"2017","unstructured":"Freeman ML, Morris SR, Lederman MM. CD161 Expression on Mucosa-Associated Invariant T Cells is Reduced in HIV-Infected Subjects Undergoing Antiretroviral Therapy Who Do Not Recover CD4(+) T Cells. Pathog Immun. 2017;2(3):335\u201351.","journal-title":"Pathog Immun"},{"issue":"5","key":"5382_CR23","doi-asserted-by":"publisher","first-page":"e1423184","DOI":"10.1080\/2162402X.2017.1423184","volume":"7","author":"VM Braud","year":"2018","unstructured":"Braud VM, Biton J, Becht E, Knockaert S, Mansuet-Lupo A, Cosson E, et al. Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome. Oncoimmunology. 2018;7(5):e1423184.","journal-title":"Oncoimmunology"},{"issue":"44","key":"5382_CR24","doi-asserted-by":"publisher","first-page":"37964","DOI":"10.1074\/jbc.M111.285312","volume":"286","author":"C Germain","year":"2011","unstructured":"Germain C, Meier A, Jensen T, Knapnougel P, Poupon G, Lazzari A, et al. Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-\u03b3 contributes to modulate immune responses. J Biol Chem. 2011;286(44):37964\u201375.","journal-title":"J Biol Chem"},{"issue":"10","key":"5382_CR25","doi-asserted-by":"publisher","first-page":"6508","DOI":"10.4049\/jimmunol.180.10.6508","volume":"180","author":"DB Rosen","year":"2008","unstructured":"Rosen DB, Cao W, Avery DT, Tangye SG, Liu YJ, Houchins JP, et al. Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells. J Immunol. 2008;180(10):6508\u201317.","journal-title":"J Immunol"},{"key":"5382_CR26","doi-asserted-by":"crossref","unstructured":"de Vicente JC, Lequerica-Fern\u00e1ndez P, Rodrigo JP, Rodr\u00edguez-Santamarta T, Blanco-Lorenzo V, Prieto-Fern\u00e1ndez L et al. Lectin-like Transcript-1 (LLT1) Expression in Oral Squamous Cell Carcinomas: Prognostic Significance and Relationship with the Tumor Immune Microenvironment. Int J Mol Sci. 2024;25(8).","DOI":"10.3390\/ijms25084314"},{"issue":"1","key":"5382_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1359\/jbmr.0301215","volume":"19","author":"YS Hu","year":"2004","unstructured":"Hu YS, Zhou H, Myers D, Quinn JM, Atkins GJ, Ly C, et al. Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts. J Bone Min Res. 2004;19(1):89\u201399.","journal-title":"J Bone Min Res"},{"issue":"1","key":"5382_CR28","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1007\/s12672-025-03749-9","volume":"16","author":"W Zhu","year":"2025","unstructured":"Zhu W, Zeng X, Qin J, Qi X, Zhou W. Adenylosuccinate lyase (ADSL) is a pan-cancer prognostic and immune biomarker with distinct roles in hepatocellular carcinoma. Discov Oncol. 2025;16(1):2119.","journal-title":"Discov Oncol"},{"issue":"15","key":"5382_CR29","doi-asserted-by":"publisher","first-page":"e37688","DOI":"10.1097\/MD.0000000000037688","volume":"103","author":"L Li","year":"2024","unstructured":"Li L, Hu Y, Li X, Ju B. A comprehensive analysis of the KLRB1 expression and its clinical implication in testicular germ cell tumors: A review. Med (Baltim). 2024;103(15):e37688.","journal-title":"Med (Baltim)"},{"issue":"12","key":"5382_CR30","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.21037\/tcr-23-697","volume":"12","author":"C Liang","year":"2023","unstructured":"Liang C, Chen Y, Chen S, She J, Shi Q, Wang P. KLRB1 is a novel prognostic biomarker in endometrial cancer and is associated with immune infiltration. Transl Cancer Res. 2023;12(12):3641\u201352.","journal-title":"Transl Cancer Res"},{"key":"5382_CR31","doi-asserted-by":"publisher","first-page":"1185799","DOI":"10.3389\/fendo.2023.1185799","volume":"14","author":"G Huang","year":"2023","unstructured":"Huang G, Xiao S, Jiang Z, Zhou X, Chen L, Long L, et al. Machine learning immune-related gene based on KLRB1 model for predicting the prognosis and immune cell infiltration of breast cancer. Front Endocrinol (Lausanne). 2023;14:1185799.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5382_CR32","doi-asserted-by":"publisher","first-page":"e15654","DOI":"10.7717\/peerj.15654","volume":"11","author":"N Xu","year":"2023","unstructured":"Xu N, Meng X, Chu H, Yang Z, Jiao Y, Li Y. The prognostic significance of KLRB1 and its further association with immune cells in breast cancer. PeerJ. 2023;11:e15654.","journal-title":"PeerJ"},{"key":"5382_CR33","doi-asserted-by":"crossref","unstructured":"Zhou J, Wu C, Li S. CNS Germ Cell Tumors: Molecular Advances, Significance in Risk Stratification and Future Directions. Brain Sci. 2024;14(5).","DOI":"10.3390\/brainsci14050445"},{"issue":"1","key":"5382_CR34","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12876-024-03299-4","volume":"24","author":"S Fang","year":"2024","unstructured":"Fang S, Zhou Y. Deciphering the role of KLRB1: a novel prognostic indicator in hepatocellular carcinoma. BMC Gastroenterol. 2024;24(1):210.","journal-title":"BMC Gastroenterol"},{"issue":"11","key":"5382_CR35","doi-asserted-by":"publisher","first-page":"e1493","DOI":"10.1002\/ctm2.1493","volume":"13","author":"H Huang","year":"2023","unstructured":"Huang H, Li N, Liang Y, Li R, Tong X, Xiao J, et al. Multi-omics analyses reveal spatial heterogeneity in primary and metastatic oesophageal squamous cell carcinoma. Clin Transl Med. 2023;13(11):e1493.","journal-title":"Clin Transl Med"},{"issue":"1","key":"5382_CR36","doi-asserted-by":"publisher","first-page":"10374","DOI":"10.1038\/s41598-025-93916-3","volume":"15","author":"J Fan","year":"2025","unstructured":"Fan J, Chen Y, Gong Y, Sun H, Hou R, Dou X, et al. Single-cell RNA sequencing reveals potential therapeutic targets in the tumor microenvironment of lung squamous cell carcinoma. Sci Rep. 2025;15(1):10374.","journal-title":"Sci Rep"},{"issue":"1","key":"5382_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41568-018-0081-9","volume":"19","author":"NK Altorki","year":"2019","unstructured":"Altorki NK, Markowitz GJ, Gao D, Port JL, Saxena A, Stiles B, et al. The lung microenvironment: an important regulator of tumour growth and metastasis. Nat Rev Cancer. 2019;19(1):9\u201331.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"5382_CR38","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/s41467-021-22801-0","volume":"12","author":"F Wu","year":"2021","unstructured":"Wu F, Fan J, He Y, Xiong A, Yu J, Li Y, et al. Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer. Nat Commun. 2021;12(1):2540.","journal-title":"Nat Commun"},{"key":"5382_CR39","doi-asserted-by":"crossref","unstructured":"Lu H, Qian J, Cheng L, Shen Y, Chu T, Zhao C. Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma. BMJ Open Respir Res. 2023;10(1).","DOI":"10.1136\/bmjresp-2023-001878"},{"key":"5382_CR40","doi-asserted-by":"publisher","first-page":"889686","DOI":"10.3389\/fonc.2022.889686","volume":"12","author":"L Pohl","year":"2022","unstructured":"Pohl L, Friedhoff J, Jurcic C, Teroerde M, Schindler I, Strepi K, et al. Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and Opportunities. Front Oncol. 2022;12:889686.","journal-title":"Front Oncol"},{"key":"5382_CR41","doi-asserted-by":"crossref","unstructured":"Monjaras-Avila CU, Lorenzo-Leal AC, Luque-Badillo AC, D\u2019Costa N, Chavez-Mu\u00f1oz C, Bach H. The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma. Int J Mol Sci. 2023;24(9).","DOI":"10.3390\/ijms24097946"},{"issue":"4","key":"5382_CR42","doi-asserted-by":"publisher","first-page":"e1305535","DOI":"10.1080\/2162402X.2017.1305535","volume":"6","author":"PJ Siska","year":"2017","unstructured":"Siska PJ, Johnpulle RAN, Zhou A, Bordeaux J, Kim JY, Dabbas B, et al. Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling. Oncoimmunology. 2017;6(4):e1305535.","journal-title":"Oncoimmunology"},{"issue":"5","key":"5382_CR43","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cell.2021.01.022","volume":"184","author":"ND Mathewson","year":"2021","unstructured":"Mathewson ND, Ashenberg O, Tirosh I, Gritsch S, Perez EM, Marx S, et al. Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis. Cell. 2021;184(5):1281\u2013e9826.","journal-title":"Cell"},{"issue":"10","key":"5382_CR44","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1038\/bjc.2014.162","volume":"110","author":"S Han","year":"2014","unstructured":"Han S, Zhang C, Li Q, Dong J, Liu Y, Huang Y, et al. Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma. Br J Cancer. 2014;110(10):2560\u20138.","journal-title":"Br J Cancer"},{"key":"5382_CR45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41698-020-00133-4","volume":"4","author":"Z Li","year":"2020","unstructured":"Li Z, Zheng B, Qiu X, Wu R, Wu T, Yang S, et al. The identification and functional analysis of CD8\u2009+\u2009PD-1\u2009+\u2009CD161+ T cells in hepatocellular carcinoma. NPJ Precis Oncol. 2020;4:28.","journal-title":"NPJ Precis Oncol"},{"issue":"8","key":"5382_CR46","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3748\/wjg.v26.i8.789","volume":"26","author":"L Pan","year":"2020","unstructured":"Pan L, Fang J, Chen MY, Zhai ST, Zhang B, Jiang ZY, et al. Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma. World J Gastroenterol. 2020;26(8):789\u2013803.","journal-title":"World J Gastroenterol"},{"key":"5382_CR47","doi-asserted-by":"publisher","first-page":"5263","DOI":"10.2147\/OTT.S332822","volume":"14","author":"J Mo","year":"2021","unstructured":"Mo J, Zheng L, Gao Z, Wu J, Bao Y. The Study of Mucosal-Associated Invariant T Cells in Colon Cancer and Roles in Immune Activities. Onco Targets Ther. 2021;14:5263\u201373.","journal-title":"Onco Targets Ther"},{"issue":"22","key":"5382_CR48","doi-asserted-by":"publisher","first-page":"13265","DOI":"10.18632\/aging.205239","volume":"15","author":"JR He","year":"2023","unstructured":"He JR, Li D, Zhang QX, Liu T, Ding Y, Wu CY, et al. Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients. Aging. 2023;15(22):13265\u201386.","journal-title":"Aging"},{"issue":"6","key":"5382_CR49","doi-asserted-by":"publisher","first-page":"e27294","DOI":"10.1016\/j.heliyon.2024.e27294","volume":"10","author":"J Xia","year":"2024","unstructured":"Xia J, Zhou X. Necroptosis-related KLRB1 was a potent tumor suppressor and immunotherapy determinant in breast cancer. Heliyon. 2024;10(6):e27294.","journal-title":"Heliyon"},{"issue":"1","key":"5382_CR50","doi-asserted-by":"publisher","first-page":"11782","DOI":"10.1038\/s41598-024-60414-x","volume":"14","author":"JL Chen","year":"2024","unstructured":"Chen JL, Wu CY, Luo XY, Wang XY, Wang FM, Huang X, et al. Down-regulation of KLRB1 is associated with increased cell growth, metastasis, poor prognosis, as well as a dysfunctional immune microenvironment in LUAD. Sci Rep. 2024;14(1):11782.","journal-title":"Sci Rep"},{"issue":"1","key":"5382_CR51","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/JS9.0000000000003459","volume":"112","author":"Y Chen","year":"2026","unstructured":"Chen Y, Liu T, Min G, Wang C, Xi D, Jiang L. Single-cell transcriptome analysis reveals regulatory programs associated with tumor resistance during immunotherapy in colorectal cancer. Int J Surg. 2026;112(1):694\u2013708.","journal-title":"Int J Surg"},{"key":"5382_CR52","doi-asserted-by":"publisher","first-page":"571641","DOI":"10.3389\/fmolb.2020.571641","volume":"7","author":"C Ma","year":"2020","unstructured":"Ma C, Luo H, Cao J, Zheng X, Zhang J, Zhang Y, et al. Identification of a Novel Tumor Microenvironment-Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma. Front Mol Biosci. 2020;7:571641.","journal-title":"Front Mol Biosci"},{"issue":"21","key":"5382_CR53","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.7150\/jca.63236","volume":"12","author":"W Ye","year":"2021","unstructured":"Ye W, Luo C, Li C, Liu Z, Liu F. CD161, a promising Immune Checkpoint, correlates with Patient Prognosis: A Pan-cancer Analysis. J Cancer. 2021;12(21):6588\u201399.","journal-title":"J Cancer"},{"issue":"7","key":"5382_CR54","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2174\/1386207323666200517114154","volume":"23","author":"G Zhang","year":"2020","unstructured":"Zhang G, Liu Y, Dong F, Liu X. Transcription\/Expression of KLRB1 Gene as A Prognostic Indicator in Human Esophageal Squamous Cell Carcinoma. Comb Chem High Throughput Screen. 2020;23(7):667\u201374.","journal-title":"Comb Chem High Throughput Screen"},{"key":"5382_CR55","unstructured":"Pleshkan VV, Zinov\u2019eva MV, Vinogradova TV, Sverdlov ED. [Transcription of the KLRB1 gene is suppressed in human cancer tissues]. Mol Gen Mikrobiol Virusol. 2007(4):3\u20137."},{"issue":"4","key":"5382_CR56","doi-asserted-by":"publisher","first-page":"109389","DOI":"10.1016\/j.isci.2024.109389","volume":"27","author":"Y Shi","year":"2024","unstructured":"Shi Y, Ye R, Gao Y, Xia F, Yu XF. A prognostic and immune related risk model based on zinc homeostasis in hepatocellular carcinoma. iScience. 2024;27(4):109389.","journal-title":"iScience"},{"key":"5382_CR57","doi-asserted-by":"publisher","first-page":"394632023121817","DOI":"10.1177\/03946320231218179","volume":"37","author":"P Li","year":"2023","unstructured":"Li P, Ma X, Huang D, Gu X. Development and evaluation of a risk score model based on a WNT score gene-associated signature for predicting the clinical outcome and the tumour microenvironment of hepatocellular carcinoma. Int J Immunopathol Pharmacol. 2023;37:3946320231218179.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"5382_CR58","doi-asserted-by":"publisher","first-page":"16556","DOI":"10.1038\/s41598-025-01212-x","volume":"15","author":"Y Yu","year":"2025","unstructured":"Yu Y, Yin W, Feng J, Qian S. Development and validation of a risk model for effective immune and stromal related signature predicting prognosis of patients with ovarian cancer. Sci Rep. 2025;15(1):16556.","journal-title":"Sci Rep"},{"key":"5382_CR59","doi-asserted-by":"crossref","unstructured":"Zheng M, Mullikin H, Hester A, Czogalla B, Heidegger H, Vilsmaier T et al. Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile. Int J Mol Sci. 2020;21(23).","DOI":"10.3390\/ijms21239169"},{"issue":"3","key":"5382_CR60","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.21037\/tcr-23-1231","volume":"13","author":"X Liu","year":"2024","unstructured":"Liu X, Cui Q, Qin N. Low expression of KLRB1 predicts poor survival outcomes and is associated with immune infiltration in breast cancer. Transl Cancer Res. 2024;13(3):1225\u201340.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"5382_CR61","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41597-023-02032-2","volume":"10","author":"H Zhao","year":"2023","unstructured":"Zhao H, Yin X, Wang L, Liu K, Liu W, Bo L, et al. Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer. Sci Data. 2023;10(1):119.","journal-title":"Sci Data"},{"key":"5382_CR62","doi-asserted-by":"publisher","first-page":"1460607","DOI":"10.3389\/fimmu.2024.1460607","volume":"15","author":"Q Hou","year":"2024","unstructured":"Hou Q, Li C, Chong Y, Yin H, Guo Y, Yang L, et al. Comprehensive single-cell and bulk transcriptomic analyses to develop an NK cell-derived gene signature for prognostic assessment and precision medicine in breast cancer. Front Immunol. 2024;15:1460607.","journal-title":"Front Immunol"},{"issue":"1","key":"5382_CR63","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12894-022-00955-3","volume":"22","author":"F Tang","year":"2022","unstructured":"Tang F, Li Z, Lai Y, Lu Z, Lei H, He C, et al. A 7-gene signature predicts the prognosis of patients with bladder cancer. BMC Urol. 2022;22(1):8.","journal-title":"BMC Urol"},{"key":"5382_CR64","doi-asserted-by":"publisher","first-page":"112908","DOI":"10.1016\/j.intimp.2024.112908","volume":"140","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Zhang H, Shao R, Wu X, Ding Y, Li Y, et al. Comprehensive pan-cancer analysis of KLRB1-CLEC2D pair and identification of small molecule inhibitors to disrupt their interaction. Int Immunopharmacol. 2024;140:112908.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"5382_CR65","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3892\/ol.2025.15286","volume":"30","author":"A Wang","year":"2025","unstructured":"Wang A, Li X, Wang Z, Chen L. Prognostic value of M2 macrophage-related genes and their importance in the immunotherapy response in hepatocellular carcinoma. Oncol Lett. 2025;30(6):540.","journal-title":"Oncol Lett"},{"issue":"2","key":"5382_CR66","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cell.2020.11.041","volume":"184","author":"Y Sun","year":"2021","unstructured":"Sun Y, Wu L, Zhong Y, Zhou K, Hou Y, Wang Z, et al. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma. Cell. 2021;184(2):404\u2013e2116.","journal-title":"Cell"},{"issue":"17","key":"5382_CR67","doi-asserted-by":"publisher","first-page":"e71202","DOI":"10.1002\/cam4.71202","volume":"14","author":"D Li","year":"2025","unstructured":"Li D, Liu J, Yu L, Luo X, Wu X, Chen R. Integrated Single-Cell RNA-Seq Reveals Immunosuppressive Mechanisms of Treg Cell Differentiation and Tumor Microenvironment Interactions in Colorectal Cancer. Cancer Med. 2025;14(17):e71202.","journal-title":"Cancer Med"},{"issue":"1","key":"5382_CR68","doi-asserted-by":"publisher","first-page":"7333","DOI":"10.1038\/s41467-021-27452-9","volume":"12","author":"F Yao","year":"2021","unstructured":"Yao F, Deng Y, Zhao Y, Mei Y, Zhang Y, Liu X, et al. A targetable LIFR-NF-\u03baB-LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis. Nat Commun. 2021;12(1):7333.","journal-title":"Nat Commun"},{"issue":"11","key":"5382_CR69","first-page":"1251","volume":"22","author":"ZZ Chong","year":"2007","unstructured":"Chong ZZ, Maiese K. The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histol Histopathol. 2007;22(11):1251\u201367.","journal-title":"Histol Histopathol"},{"issue":"7","key":"5382_CR70","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1111\/jcmm.12524","volume":"19","author":"M Pesce","year":"2015","unstructured":"Pesce M, Franceschelli S, Ferrone A, De Lutiis MA, Patruno A, Grilli A, et al. Verbascoside down-regulates some pro-inflammatory signal transduction pathways by increasing the activity of tyrosine phosphatase SHP-1 in the U937 cell line. J Cell Mol Med. 2015;19(7):1548\u201356.","journal-title":"J Cell Mol Med"},{"issue":"39","key":"5382_CR71","doi-asserted-by":"publisher","first-page":"27583","DOI":"10.1074\/jbc.274.39.27583","volume":"274","author":"B Cuevas","year":"1999","unstructured":"Cuevas B, Lu Y, Watt S, Kumar R, Zhang J, Siminovitch KA, et al. SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity. J Biol Chem. 1999;274(39):27583\u20139.","journal-title":"J Biol Chem"},{"issue":"29","key":"5382_CR72","doi-asserted-by":"publisher","first-page":"27455","DOI":"10.1074\/jbc.M100556200","volume":"276","author":"BD Cuevas","year":"2001","unstructured":"Cuevas BD, Lu Y, Mao M, Zhang J, LaPushin R, Siminovitch K, et al. Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase. J Biol Chem. 2001;276(29):27455\u201361.","journal-title":"J Biol Chem"},{"issue":"21","key":"5382_CR73","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1091\/mbc.e11-04-0373","volume":"22","author":"M Lodeiro","year":"2011","unstructured":"Lodeiro M, Al\u00e9n BO, Mosteiro CS, Beiroa D, Nogueiras R, Theodoropoulou M, et al. The SHP-1 protein tyrosine phosphatase negatively modulates Akt signaling in the ghrelin\/GHSR1a system. Mol Biol Cell. 2011;22(21):4182\u201391.","journal-title":"Mol Biol Cell"},{"key":"5382_CR74","doi-asserted-by":"publisher","first-page":"e19055","DOI":"10.7717\/peerj.19055","volume":"13","author":"J Wang","year":"2025","unstructured":"Wang J, Wang X, Shi J, Wang Y, Mi L, Zhao M, et al. CD161, a promising prognostic biomarker in hepatocellular carcinoma, correlates with immune infiltration. PeerJ. 2025;13:e19055.","journal-title":"PeerJ"},{"issue":"2","key":"5382_CR75","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1158\/1078-0432.CCR-23-2213","volume":"30","author":"J Li","year":"2024","unstructured":"Li J, Hu H, Qin G, Bai F, Wu X, Ke H, et al. Biomarkers of Pathologic Complete Response to Neoadjuvant Immunotherapy in Mismatch Repair-Deficient Colorectal Cancer. Clin Cancer Res. 2024;30(2):368\u201378.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"5382_CR76","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12943-024-02155-z","volume":"23","author":"F Qi","year":"2024","unstructured":"Qi F, Gao N, Li J, Zhou C, Jiang J, Zhou B, et al. A multidimensional recommendation framework for identifying biological targets to aid the diagnosis and treatment of liver metastasis in patients with colorectal cancer. Mol Cancer. 2024;23(1):239.","journal-title":"Mol Cancer"},{"key":"5382_CR77","doi-asserted-by":"publisher","first-page":"107459","DOI":"10.1016\/j.compbiomed.2023.107459","volume":"165","author":"J Zhang","year":"2023","unstructured":"Zhang J, Liu Y, Xia L, Zhen J, Gao J, Atsushi T. Constructing heterogeneous single-cell landscape and identifying microenvironment molecular characteristics of primary and lymphatic metastatic head and neck squamous cell carcinoma. Comput Biol Med. 2023;165:107459.","journal-title":"Comput Biol Med"},{"issue":"3","key":"5382_CR78","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1158\/2326-6066.CIR-22-0454","volume":"11","author":"Y Wei","year":"2023","unstructured":"Wei Y, Xu T, Li C, Zhou X, Qian W, Shen C, et al. CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus-Driven Oropharyngeal Cancer. Cancer Immunol Res. 2023;11(3):306\u201319.","journal-title":"Cancer Immunol Res"},{"issue":"13","key":"5382_CR79","doi-asserted-by":"publisher","first-page":"11411","DOI":"10.1007\/s00432-023-05017-1","volume":"149","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Yang J, Xie S, Chen H, Zhong J, Lin X, et al. A novel prognostic signature based on immunogenic cell death score predicts outcomes and response to transcatheter arterial chemoembolization and immunotherapy in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2023;149(13):11411\u201329.","journal-title":"J Cancer Res Clin Oncol"},{"key":"5382_CR80","doi-asserted-by":"crossref","unstructured":"Wu B, Li L, Li L, Chen Y, Guan Y, Zhao J. Integration of Bioinformatics and Machine Learning to Identify CD8\u2009+\u2009T Cell-Related Prognostic Signature to Predict Clinical Outcomes and Treatment Response in Breast Cancer Patients. Genes (Basel). 2024;15(8).","DOI":"10.3390\/genes15081093"},{"key":"5382_CR81","doi-asserted-by":"publisher","first-page":"1580315","DOI":"10.3389\/fimmu.2025.1580315","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Ding Y, Liu H, Xia Z, Liao G, Fan S, et al. Therapeutic implications of cancer-associated fibroblast heterogeneity: insights from single-cell and multi-omics analysis. Front Immunol. 2025;16:1580315.","journal-title":"Front Immunol"},{"key":"5382_CR82","doi-asserted-by":"publisher","first-page":"e18521","DOI":"10.7717\/peerj.18521","volume":"12","author":"J Gao","year":"2024","unstructured":"Gao J, Yan X, Fan D, Li Y. Single-cell data revealed the function of natural killer cells and macrophage cells in chemotherapy tolerance in acute myeloid leukemia. PeerJ. 2024;12:e18521.","journal-title":"PeerJ"},{"key":"5382_CR83","doi-asserted-by":"publisher","first-page":"1445858","DOI":"10.3389\/fimmu.2024.1445858","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Wang L, Yu B, Su J, Dong S. IL7R, GZMA and CD8A serve as potential molecular biomarkers for sepsis based on bioinformatics analysis. Front Immunol. 2024;15:1445858.","journal-title":"Front Immunol"},{"key":"5382_CR84","doi-asserted-by":"publisher","first-page":"6788569","DOI":"10.1155\/2022\/6788569","volume":"2022","author":"G Liang","year":"2022","unstructured":"Liang G, Li J, Pu S, He Z. Screening of Sepsis Biomarkers Based on Bioinformatics Data Analysis. J Healthc Eng. 2022;2022:6788569.","journal-title":"J Healthc Eng"},{"key":"5382_CR85","doi-asserted-by":"publisher","first-page":"1264873","DOI":"10.3389\/fgene.2023.1264873","volume":"14","author":"H Chen","year":"2023","unstructured":"Chen H, Chen E, Lu Y, Xu Y. Identification of immune-related genes in diagnosing retinopathy of prematurity with sepsis through bioinformatics analysis and machine learning. Front Genet. 2023;14:1264873.","journal-title":"Front Genet"},{"key":"5382_CR86","doi-asserted-by":"publisher","first-page":"1257834","DOI":"10.3389\/fimmu.2023.1257834","volume":"14","author":"G Qian","year":"2023","unstructured":"Qian G, Fang H, Chen A, Sun Z, Huang M, Luo M, et al. A hub gene signature as a therapeutic target and biomarker for sepsis and geriatric sepsis-induced ARDS concomitant with COVID-19 infection. Front Immunol. 2023;14:1257834.","journal-title":"Front Immunol"},{"issue":"1","key":"5382_CR87","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12879-025-10818-5","volume":"25","author":"W Chen","year":"2025","unstructured":"Chen W, Haoran C, Jinqiu D, Xinyi T, Dian Y, Yongpeng X, et al. Candidate target genes in sepsis diagnosis and therapy: identifying hub genes with a spotlight on KLRB1. BMC Infect Dis. 2025;25(1):409.","journal-title":"BMC Infect Dis"},{"key":"5382_CR88","doi-asserted-by":"publisher","first-page":"1374763","DOI":"10.3389\/fimmu.2024.1374763","volume":"15","author":"Z Ma","year":"2024","unstructured":"Ma Z, An P, Hao S, Huang Z, Yin A, Li Y, et al. Single-cell sequencing analysis and multiple machine-learning models revealed the cellular crosstalk of dendritic cells and identified FABP5 and KLRB1 as novel biomarkers for psoriasis. Front Immunol. 2024;15:1374763.","journal-title":"Front Immunol"},{"key":"5382_CR89","doi-asserted-by":"publisher","first-page":"726529","DOI":"10.3389\/fphar.2021.726529","volume":"12","author":"J Lu","year":"2021","unstructured":"Lu J, Bi Y, Zhu Y, Huipeng S, Duan W, Zhou J. CD3D, GZMK, and KLRB1 Are Potential Markers for Early Diagnosis of Rheumatoid Arthritis, Especially in Anti-Citrullinated Protein Antibody-Negative Patients. Front Pharmacol. 2021;12:726529.","journal-title":"Front Pharmacol"},{"issue":"11","key":"5382_CR90","doi-asserted-by":"publisher","first-page":"e79370","DOI":"10.1371\/journal.pone.0079370","volume":"8","author":"P Chalan","year":"2013","unstructured":"Chalan P, Kroesen BJ, van der Geest KS, Huitema MG, Abdulahad WH, Bijzet J, et al. Circulating CD4\u2009+\u2009CD161+ T lymphocytes are increased in seropositive arthralgia patients but decreased in patients with newly diagnosed rheumatoid arthritis. PLoS ONE. 2013;8(11):e79370.","journal-title":"PLoS ONE"},{"issue":"1","key":"5382_CR91","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10238-015-0402-1","volume":"17","author":"YL Lin","year":"2017","unstructured":"Lin YL, Lin SC. Analysis of the CD161-expressing cell quantities and CD161 expression levels in peripheral blood natural killer and T cells of systemic lupus erythematosus patients. Clin Exp Med. 2017;17(1):101\u20139.","journal-title":"Clin Exp Med"},{"key":"5382_CR92","doi-asserted-by":"publisher","first-page":"1354348","DOI":"10.3389\/fimmu.2024.1354348","volume":"15","author":"HW Sun","year":"2024","unstructured":"Sun HW, Zhang X, Shen CC. The shared circulating diagnostic biomarkers and molecular mechanisms of systemic lupus erythematosus and inflammatory bowel disease. Front Immunol. 2024;15:1354348.","journal-title":"Front Immunol"},{"key":"5382_CR93","doi-asserted-by":"crossref","unstructured":"Inamo J, Keegan J, Griffith A, Ghosh T, Horisberger A, Howard K et al. Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis. J Clin Invest. 2025;135(6).","DOI":"10.1172\/JCI185217"},{"issue":"1","key":"5382_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12672-023-00852-7","volume":"15","author":"C Jiang","year":"2024","unstructured":"Jiang C, Jiang W, Liu P, Sun W, Teng W. Exploring the relationship between immune heterogeneity characteristic genes of rheumatoid arthritis and acute myeloid leukemia. Discov Oncol. 2024;15(1):1.","journal-title":"Discov Oncol"},{"key":"5382_CR95","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-4933-2-14","volume":"2","author":"L Ginaldi","year":"2005","unstructured":"Ginaldi L, Di Benedetto MC, De Martinis M. Osteoporosis, inflammation and ageing. Immun Ageing. 2005;2:14.","journal-title":"Immun Ageing"},{"key":"5382_CR96","doi-asserted-by":"crossref","unstructured":"Shi X, Tang L, Li M, Wu Y, Xu Y. CD4\u2009+\u2009Effector Memory T Cells Related Marker Gene Signatures in Osteoporosis and Aging: Insight From Single-Cell Analysis and Mendelian Randomization. Comb Chem High Throughput Screen; 2025.","DOI":"10.2174\/0113862073353509241205065221"},{"key":"5382_CR97","doi-asserted-by":"crossref","unstructured":"Andric F, Al-Fairouzi A, Wettergren Y, Szeponik L, Bexe-Lindskog E, Cusack JC Jr. et al. Immune Microenvironment in Sporadic Early-Onset versus Average-Onset Colorectal Cancer. Cancers (Basel). 2023;15(5).","DOI":"10.3390\/cancers15051457"},{"issue":"4","key":"5382_CR98","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.gendis.2020.01.007","volume":"8","author":"Z Wei","year":"2021","unstructured":"Wei Z, Yang Y, Li Q, Yin Y, Wei Z, Zhang W, et al. The transcriptome of circulating cells indicates potential biomarkers and therapeutic targets in the course of hypertension-related myocardial infarction. Genes Dis. 2021;8(4):555\u201368.","journal-title":"Genes Dis"},{"issue":"1","key":"5382_CR99","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12967-020-02400-1","volume":"18","author":"G Osmak","year":"2020","unstructured":"Osmak G, Baulina N, Koshkin P, Favorova O. Collapsing the list of myocardial infarction-related differentially expressed genes into a diagnostic signature. J Transl Med. 2020;18(1):231.","journal-title":"J Transl Med"},{"key":"5382_CR100","doi-asserted-by":"publisher","first-page":"112072","DOI":"10.1016\/j.intimp.2024.112072","volume":"133","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Bahabayi A, Liu D, Hasimu A, Zhang Y, Guo S, et al. KLRB1 defines an activated phenotype of CD4\u2009+\u2009T cells and shows significant upregulation in patients with primary Sj\u00f6gren\u2019s syndrome. Int Immunopharmacol. 2024;133:112072.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"5382_CR101","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/10799893.2025.2582097","volume":"45","author":"J Zhou","year":"2025","unstructured":"Zhou J, Zhang S. ZC3H13-induced KLRB1 upregulation relieves the injury of myocardial infarction through N [6]-methyladenosine methylation. J Recept Signal Transduct Res. 2025;45(6):281\u201390.","journal-title":"J Recept Signal Transduct Res"},{"issue":"4","key":"5382_CR102","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.jaad.2025.11.081","volume":"94","author":"H Wang","year":"2026","unstructured":"Wang H, Zhang L, Xu X, Le Y, Cao H, Quan C, et al. KLRB1 and IL12RB1 are pretherapeutic predictors of time to relapse in patients with psoriasis treated with IL-17 blockade. J Am Acad Dermatol. 2026;94(4):1158\u201366.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"5382_CR103","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ard.2025.01.022","volume":"84","author":"AM Gaydosik","year":"2025","unstructured":"Gaydosik AM, Tabib T, Das J, Larregina A, Lafyatis R, Fuschiotti P. Dysfunctional KLRB1(+)CD8(+) T-cell responses are generated in chronically inflamed systemic sclerosis skin. Ann Rheum Dis. 2025;84(5):798\u2013809.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5382_CR104","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12885-025-15484-z","volume":"26","author":"Y Xu","year":"2025","unstructured":"Xu Y, Wei Z, Li M, Yang W, Chen Z, Shi R, et al. Identification and prioritization of high-frequency biomarkers and therapeutic targets in gastric cancer trials. BMC Cancer. 2025;26(1):148.","journal-title":"BMC Cancer"},{"issue":"1","key":"5382_CR105","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1038\/s41598-025-86846-7","volume":"15","author":"M Garc\u00eda-Aranda","year":"2025","unstructured":"Garc\u00eda-Aranda M, Onieva M, Mart\u00edn-Garc\u00eda D, Quir\u00f3s R, L\u00f3pez I, Padilla-Ruiz M, et al. KLRB1 expression in nasopharyngeal mucosa as a prognostic biomarker in COVID-19 patients. Sci Rep. 2025;15(1):3079.","journal-title":"Sci Rep"},{"issue":"6","key":"5382_CR106","first-page":"2749","volume":"12","author":"J Lu","year":"2020","unstructured":"Lu J, Li Q, Wu Z, Zhong Z, Ji P, Li H, et al. Two gene set variation indexes as potential diagnostic tool for sepsis. Am J Transl Res. 2020;12(6):2749\u201359.","journal-title":"Am J Transl Res"},{"key":"5382_CR107","doi-asserted-by":"publisher","first-page":"9957569","DOI":"10.1155\/2021\/9957569","volume":"2021","author":"M Zhou","year":"2021","unstructured":"Zhou M, Guo R, Wang YF, Yang W, Li R, Lu L. Application of Weighted Gene Coexpression Network Analysis to Identify Key Modules and Hub Genes in Systemic Juvenile Idiopathic Arthritis. Biomed Res Int. 2021;2021:9957569.","journal-title":"Biomed Res Int"},{"key":"5382_CR108","doi-asserted-by":"publisher","first-page":"578811","DOI":"10.1016\/j.jneuroim.2025.578811","volume":"410","author":"R Jia","year":"2026","unstructured":"Jia R, Yao X, Liu Q, Wang X. Identification of the core genes KLRB1 and RETN as potential shared diagnostic markers for major depressive disorder and systemic lupus erythematosus through bioinformatics and machine learning methodologies. J Neuroimmunol. 2026;410:578811.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"5382_CR109","doi-asserted-by":"publisher","first-page":"14111","DOI":"10.1038\/s41598-022-18340-3","volume":"12","author":"SM Choi","year":"2022","unstructured":"Choi SM, Park HJ, Choi EA, Jung KC, Lee JI. Heterogeneity of circulating CD4(+)CD8(+) double-positive T cells characterized by scRNA-seq analysis and trajectory inference. Sci Rep. 2022;12(1):14111.","journal-title":"Sci Rep"},{"issue":"4","key":"5382_CR110","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s12072-025-10799-2","volume":"19","author":"W Zhu","year":"2025","unstructured":"Zhu W, Fan C, Zhao Y, Liu Y, Cheng Y, Zhou W. Breaking bottlenecks: the future of hepatocellular carcinoma clinical trials and therapeutic targets. Hepatol Int. 2025;19(4):888\u2013902.","journal-title":"Hepatol Int"},{"issue":"9","key":"5382_CR111","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.7150\/ijbs.113213","volume":"21","author":"C Zeng","year":"2025","unstructured":"Zeng C, Wang J, Zhao S, Wei Y, Qi Y, Liu S, et al. Multi-cohort validation of a lipid metabolism and ferroptosis-associated index for prognosis and immunotherapy response prediction in hormone receptor-positive breast cancer. Int J Biol Sci. 2025;21(9):3968\u201392.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"5382_CR112","doi-asserted-by":"publisher","first-page":"45161","DOI":"10.1038\/s41598-025-28296-9","volume":"15","author":"L Hu","year":"2025","unstructured":"Hu L, Chen C, Xiao Y, Li Z, Jiang N, Du C, et al. Prognostic impact of tertiary lymphoid structures and cancer-associated fibroblasts in hepatocellular carcinoma with portal vein tumor thrombus. Sci Rep. 2025;15(1):45161.","journal-title":"Sci Rep"},{"issue":"24","key":"5382_CR113","doi-asserted-by":"publisher","first-page":"e71370","DOI":"10.1096\/fj.202503152R","volume":"39","author":"W Zhu","year":"2025","unstructured":"Zhu W, Fan C, Wang H, Shi R, Yang Z, Qin J, et al. Proton-Pump Inhibitor Use and Gastrointestinal Disease Risk: A Mendelian Randomization Study of Omics and Pharmacological Pathways. Faseb j. 2025;39(24):e71370.","journal-title":"Faseb j"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05382-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05382-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05382-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:02:33Z","timestamp":1787184153000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05382-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5382"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05382-6","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1213"}}